276 related articles for article (PubMed ID: 19387532)
41. Diagnostic imaging of hepatocellular carcinoma: recent progress.
Kudo M
Oncology; 2011; 81 Suppl 1():73-85. PubMed ID: 22212940
[TBL] [Abstract][Full Text] [Related]
42. Efficacy of fusion imaging combining sonography and hepatobiliary phase MRI with Gd-EOB-DTPA to detect small hepatocellular carcinoma.
Kunishi Y; Numata K; Morimoto M; Okada M; Kaneko T; Maeda S; Tanaka K
AJR Am J Roentgenol; 2012 Jan; 198(1):106-14. PubMed ID: 22194485
[TBL] [Abstract][Full Text] [Related]
43. Clinical utility of contrast-enhanced three-dimensional ultrasound imaging with Sonazoid: findings on hepatocellular carcinoma lesions.
Luo W; Numata K; Morimoto M; Nozaki A; Nagano Y; Sugimori K; Zhou X; Tanaka K
Eur J Radiol; 2009 Dec; 72(3):425-31. PubMed ID: 18930616
[TBL] [Abstract][Full Text] [Related]
44. Three cases of histologically proven hepatic epithelioid hemangioendothelioma evaluated using a second-generation microbubble contrast medium in ultrasonography: case reports.
Arai J; Shimozuma Y; Otoyama Y; Sugiura I; Nakajima Y; Hayashi E; Kajiwara A; Omori R; Uozumi S; Miyashita M; Uchikoshi M; Doi H; Sakaki M; Wang T; Eguchi J; Ito T; Kurihara T; Munechika J; Gokan T; Saito K; Miura S; Tate G; Takimoto M; Yoshida H
BMC Gastroenterol; 2019 Nov; 19(1):187. PubMed ID: 31727083
[TBL] [Abstract][Full Text] [Related]
45. Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US.
Min JH; Lim HK; Lim S; Kang TW; Song KD; Choi SY; Rhim H; Lee MW
Clin Mol Hepatol; 2014 Mar; 20(1):61-70. PubMed ID: 24757660
[TBL] [Abstract][Full Text] [Related]
46. [Early diagnosis of small hepatocellular carcinoma by new contrast-enhanced ultrasound technique].
Chen MH; Dai Y; Yan K; Fan ZH; Wu W; Wang YB; Yin SS; Yang W; Li JY
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):458-62. PubMed ID: 16224512
[TBL] [Abstract][Full Text] [Related]
47. [Focal liver lesions. A comparison between magnetic resonance under base conditions and after a superparamagentic contrast medium].
Finazzo M; Midiri M; Gallo C; Bartolotta TV; Luca A
Radiol Med; 1998 Jun; 95(6):599-607. PubMed ID: 9717542
[TBL] [Abstract][Full Text] [Related]
48. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
49. Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced mr imaging.
Kim YK; Kim CS; Kwak HS; Lee JM
J Magn Reson Imaging; 2004 Nov; 20(5):826-37. PubMed ID: 15503325
[TBL] [Abstract][Full Text] [Related]
50. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
[TBL] [Abstract][Full Text] [Related]
51. Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies: comparison with contrast-enhanced CT.
Hatanaka K; Kudo M; Minami Y; Maekawa K
Oncology; 2008; 75 Suppl 1():42-7. PubMed ID: 19092271
[TBL] [Abstract][Full Text] [Related]
52. Improved diagnosis of well-differentiated hepatocellular carcinoma with gadolinium ethoxybenzyl diethylene triamine pentaacetic acid-enhanced magnetic resonance imaging and Sonazoid contrast-enhanced ultrasonography.
Kawada N; Ohkawa K; Tanaka S; Matsunaga T; Uehara H; Ioka T; Takano Y; Takakura R; Imanaka K; Tamai C; Kawaguchi T; Tomita Y; Nakanishi K; Katayama K
Hepatol Res; 2010 Sep; 40(9):930-6. PubMed ID: 20887598
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography.
Shiozawa K; Watanabe M; Takayama R; Takahashi M; Wakui N; Iida K; Sumino Y
J Clin Ultrasound; 2010 May; 38(4):182-9. PubMed ID: 20232404
[TBL] [Abstract][Full Text] [Related]
54. Detection of hepatocellular carcinoma with ferucarbotran (resovist)-enhanced breath-hold MR imaging: feasibility of 10 minute-delayed images.
Saito K; Shindo H; Ozuki T; Ishikawa A; Kotake F; Shimazaki Y; Abe K
Magn Reson Med Sci; 2008; 7(3):123-30. PubMed ID: 18827455
[TBL] [Abstract][Full Text] [Related]
55. Deep learning approach for discrimination of liver lesions using nine time-phase images of contrast-enhanced ultrasound.
Kamiyama N; Sugimoto K; Nakahara R; Kakegawa T; Itoi T
J Med Ultrason (2001); 2024 Jan; 51(1):83-93. PubMed ID: 38051461
[TBL] [Abstract][Full Text] [Related]
56. Sonazoid-enhanced ultrasonography: comparison with CT/MRI Liver Imaging Reporting and Data System in patients with suspected hepatocellular carcinoma.
Hwang JA; Jeong WK; Min JH; Kim YY; Heo NH; Lim HK
Ultrasonography; 2021 Oct; 40(4):486-498. PubMed ID: 33745266
[TBL] [Abstract][Full Text] [Related]
57. How to detect hepatocellular carcinoma in cirrhosis.
Ward J; Robinson PJ
Eur Radiol; 2002 Sep; 12(9):2258-72. PubMed ID: 12195479
[TBL] [Abstract][Full Text] [Related]
58. Role of Contrast-Enhanced Ultrasound as a Second-Line Diagnostic Modality in Noninvasive Diagnostic Algorithms for Hepatocellular Carcinoma.
Kang HJ; Lee JM; Yoon JH; Han JK
Korean J Radiol; 2021 Mar; 22(3):354-365. PubMed ID: 33236540
[TBL] [Abstract][Full Text] [Related]
59. Kupffer-phase findings of hepatic hemangiomas in contrast-enhanced ultrasound with sonazoid.
Sugimoto K; Moriyasu F; Saito K; Yoshiara H; Imai Y
Ultrasound Med Biol; 2014 Jun; 40(6):1089-95. PubMed ID: 24556559
[TBL] [Abstract][Full Text] [Related]
60. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
